PopGenTech(美國)

PopGenTech

美國PopGenTechwww.popgentech.comPopulationGeneticsTechnologies公司通過多組個體基因組的同步分析，生產(chǎn)可加速大規(guī)模群體研究的產(chǎn)品，諾貝爾獎得主Dr.SydneyBrenner是本公司的聯(lián)合創(chuàng)始人。我們的專利技術取代了原先的樣本準備步驟，成為下一代的DNA測序技術，它克服了禁錮發(fā)現(xiàn)的成本障礙和實踐約束。Thegoalofdevelopingpe rsonalisedmedicineisdependentonidentifyingindividualsthatarelikelytobenefitfromtreatmentwithaparticulardrug.Toachievethis,cliniciansandpharmaceuticalcompaniesneedasystemfortherapiddiscoveryofclinicalbiomarkers,suchasgeneticvariants,thatareassociatedwithdiseasepredispositionanddrugefficacyortoxicity.Clinicalbiomarkersaregeneticsignpoststhatpointtoourpotentialindividualdrugresponsivenessordiseasepredisposition.Thesearefrequentlyhiddenamongmillionsofinsignificantgenevariants.Simplisticpredictionsofanewageofpersonalisedmedicine,drivenmainlybyfastersequencingtechnology,underestimatetheresourcerequiredtoidentifynewclinicalbiomarkers.